Dexmedetomidine hydrochloride (Accord Healthcare Inc.)
Welcome to the PulseAid listing for the Dexmedetomidine hydrochloride drug offered from Accord Healthcare Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],General Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Accord Healthcare Inc. |
NON-PROPRIETARY NAME: | Dexmedetomidine hydrochloride |
SUBSTANCE NAME: | DEXMEDETOMIDINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],General Anesthesia [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-12-21 |
END MARKETING DATE: | 0000-00-00 |
Dexmedetomidine hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Dexmedetomidine hydrochloride from Accord Healthcare Inc. |
LABELER NAME: | Accord Healthcare Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(ug/mL) |
START MARKETING DATE: | 2016-12-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16729-239_4e189a51-7716-6122-e054-00144ff88e88 |
PRODUCT NDC: | 16729-239 |
APPLICATION NUMBER: | ANDA204023 |
Other DEXMEDETOMIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: